{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:31:23Z","timestamp":1793655083871,"version":"4.5.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.psychres.2023.115053","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T11:15:49Z","timestamp":1673090149000},"page":"115053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation"],"prefix":"10.1016","volume":"320","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1717-2530","authenticated-orcid":false,"given":"Valerio","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-8589","authenticated-orcid":false,"given":"Laura","family":"Ciavoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Di Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Pettorruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Maina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2023.115053_bib0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.drugalcdep.2010.02.017","article-title":"An improved brief measure of cannabis misuse: the cannabis use disorders identification test-revised (CUDIT-R)","volume":"110","author":"Adamson","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2023.115053_bib0002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/0959523031000154454","article-title":"A prototype screening instrument for cannabis use disorder: the cannabis use disorders identification test (CUDIT) in an alcohol-dependent clinical sample","volume":"22","author":"Adamson","year":"2003","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.psychres.2023.115053_bib0003","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0269881119826592","article-title":"What are the psychological effects of using synthetic cannabinoids? A systematic review","volume":"33","author":"Akram","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2023.115053_bib0004","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2147\/NDT.S107622","article-title":"Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients","volume":"12","author":"Altintas","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2023.115053_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.psychres.2023.115053_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/jms.1558","article-title":"\u2018Spice\u2019 and other herbal blends: harmless incense or cannabinoid designer drugs?","author":"Auw\u00e4rter","year":"2009","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.psychres.2023.115053_bib0007","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/0269881116658990","article-title":"Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis","volume":"30","author":"Bassir Nia","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2023.115053_bib0008","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2016.04.042","article-title":"Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia","volume":"175","author":"Baudin","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2023.115053_bib0009","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the scale for suicide ideation","volume":"47","author":"Beck","year":"1979","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.psychres.2023.115053_bib0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00005053-198612000-00004","article-title":"Development, reliability, and validity of a dissociation scale","volume":"174","author":"Bernstein","year":"1986","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2023.115053_bib0011","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/eb-2014-102040","article-title":"Environmental factors, including cannabis, are strongly related to the age of onset and morbidity of schizophrenia","volume":"18","author":"Bhavsar","year":"2015","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.psychres.2023.115053_bib0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psychres.2017.01.035","article-title":"The link between dissociation and both suicide attempts and non-suicidal self-injury: meta-analyses","volume":"251","author":"Calati","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2023.115053_bib0014","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1073191116645904","article-title":"Development and validation of the dissociative symptoms scale","volume":"25","author":"Carlson","year":"2018","journal-title":"Assessment"},{"key":"10.1016\/j.psychres.2023.115053_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2023.115053_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020355","article-title":"Misuse of anticholinergic medications: a systematic review","volume":"10","author":"Chiappini","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.psychres.2023.115053_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8030040","article-title":"The effects of cannabinoids on executive functions: evidence from cannabis and synthetic cannabinoids-a systematic review","volume":"8","author":"Cohen","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.psychres.2023.115053_bib0019","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1192\/bjp.bp.109.064220","article-title":"High-potency cannabis and the risk of psychosis","volume":"195","author":"di Forti","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study","volume":"6","author":"di Forti","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0021","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00406-009-0024-2","article-title":"Cannabis and psychosis\/schizophrenia: human studies","volume":"259","author":"D'Souza","year":"2009","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2023.115053_bib0022","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2013.12.212","article-title":"Synthetic cannabinoids: analysis and metabolites","volume":"97","author":"ElSohly","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.psychres.2023.115053_bib0023","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jad.2020.09.020","article-title":"Cannabinoid use and self-injurious behaviours: a systematic review and meta-analysis","volume":"278","author":"Escelsior","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2023.115053_bib0024","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/09540261.2011.606801","article-title":"Schizophrenia guidelines across the world: a selective review and comparison","volume":"23","author":"Gaebel","year":"2011","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00406-019-01068-z","article-title":"Cannabis use and psychosis: a review of reviews","volume":"270","author":"Hasan","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2023.115053_bib0026","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/schbul\/sbi027","article-title":"The environment and schizophrenia: the role of cannabis use","volume":"31","author":"Henquet","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2023.115053_bib0027","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2023.115053_bib0028","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.166.5.654","article-title":"A brief mental health outcome scale-reliability and validity of the global assessment of functioning (GAF)","volume":"166","author":"Jones","year":"1995","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0029","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.2174\/1381612822666160919093450","article-title":"The synthetic cannabinoids phenomenon","volume":"22","author":"Karila","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.psychres.2023.115053_bib0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2023.115053_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00041","article-title":"The endocannabinoid system, aggression, and the violence of synthetic cannabinoid use, borderline personality disorder, antisocial personality disorder, and other psychiatric disorders","volume":"12","author":"Kolla","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.psychres.2023.115053_bib0032","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00406-018-0970-7","article-title":"Cannabis and mental illness: a review","volume":"269","author":"Lowe","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2023.115053_bib0033","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.psychres.2015.07.070","article-title":"Relationship between cannabis and psychosis: Reasons for use and associated clinical variables","volume":"229","author":"Man\u00e9","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2023.115053_bib0034","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-Analysis of the association between the level of cannabis use and risk of psychosis","volume":"42","author":"Marconi","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2023.115053_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11070856","article-title":"Therapeutic potentials of ketamine and esketamine in obsessive-compulsive disorder (OCD), substance use disorders (SUD) and eating disorders (ED): a review of the current literature","volume":"11","author":"Martinotti","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.psychres.2023.115053_bib0036","article-title":"Substance related exogenous psychosis: a post-modern syndrome","author":"Martinotti","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psychres.2023.115053_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18136944","article-title":"Club drugs and psychiatric sequelae: an issue of vulnerability and previous psychiatric history","volume":"18","author":"Martinotti","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.psychres.2023.115053_bib0038","doi-asserted-by":"crossref","DOI":"10.2174\/1871527316666170413101839","article-title":"Synthetic cannabinoids: psychopharmacology, clinical aspects, psychotic onset","volume":"16","author":"Martinotti","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.psychres.2023.115053_bib0039","doi-asserted-by":"crossref","DOI":"10.2174\/1871527316666170413101839","article-title":"Synthetic cannabinoids: psychopharmacology, clinical aspects, psychotic onset","volume":"16","author":"Martinotti","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.psychres.2023.115053_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2023.115053_bib0041","doi-asserted-by":"crossref","first-page":"820","DOI":"10.15288\/jsad.2012.73.820","article-title":"Measures of substance consumption among substance users, DSM-IV abusers, and those with DSM-IV dependence disorders in a nationally representative sample","volume":"73","author":"Moss","year":"2012","journal-title":"J. Stud. Alcohol Drugs"},{"key":"10.1016\/j.psychres.2023.115053_bib0042","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/wps.20341","article-title":"Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis","volume":"15","author":"Murray","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0043","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/wps.20341","article-title":"Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis","volume":"15","author":"Murray","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0044","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hup.2312","article-title":"Spiceophrenia\u201d: a systematic overview of \u201cspice\u201d-related psychopathological issues and a case report","volume":"28","author":"Papanti","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psychres.2023.115053_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009888","article-title":"Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study","volume":"6","author":"Patel","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.psychres.2023.115053_bib0046","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eurpsy.2017.12.028","article-title":"Revised manual for the global assessment of functioning scale","volume":"51","author":"Pedersen","year":"2018","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0047","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1360-0443.2007.02064.x","article-title":"The natural course of cannabis use, abuse and dependence during the first decades of life","volume":"103","author":"Perkonigg","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.psychres.2023.115053_bib0048","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1017\/S0033291720000082","article-title":"Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study","volume":"51","author":"Quattrone","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2023.115053_bib0049","article-title":"Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study","author":"Quattrone","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2023.115053_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109118","article-title":"Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study","volume":"229","author":"Ricci","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2023.115053_bib0051","article-title":"Cannabis use and suicide in non-affective psychosis: a recent literature systematic review","author":"Ricci","year":"2022","journal-title":"Braz. J. Psychiatry."},{"key":"10.1016\/j.psychres.2023.115053_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182312632","article-title":"Duration of untreated disorder and cannabis use: an observational study on a cohort of young Italian patients experiencing psychotic experiences and dissociative symptoms","volume":"18","author":"Ricci","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.psychres.2023.115053_bib0053","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1523\/JNEUROSCI.3695-04.2004","article-title":"Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area","volume":"24","author":"Riegel","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2023.115053_bib0054","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1017\/S0033291716001999","article-title":"Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder","volume":"46","author":"Ringen","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2023.115053_bib0055","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1017\/S0033291716001999","article-title":"Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder","volume":"46","author":"Ringen","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2023.115053_bib0056","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-019-2417-8","article-title":"Improving the psychometric properties of the dissociative experiences scale (DES-II): a rasch validation study","volume":"20","author":"Saggino","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0057","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2013II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.psychres.2023.115053_bib0058","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.eurpsy.2011.03.001","article-title":"Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis","volume":"27","author":"Schimmelmann","year":"2012","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0059","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2215-0366(17)30233-X","article-title":"Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis","volume":"4","author":"Schoeler","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2023.115053_bib0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/schbul\/sbv154","article-title":"Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: a report from the UK National EDEN study","volume":"42","author":"Seddon","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2023.115053_bib0061","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/schbul\/sbv154","article-title":"Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: a report from the UK National EDEN study","volume":"42","author":"Seddon","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2023.115053_bib0062","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/15504263.2019.1674991","article-title":"Cannabis use and the risk for psychosis and affective disorders","volume":"16","author":"Sideli","year":"2020","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.psychres.2023.115053_bib0063","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","article-title":"The drug abuse screening test","volume":"7","author":"Skinner","year":"1982","journal-title":"Addict. Behav."},{"key":"10.1016\/j.psychres.2023.115053_bib0064","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-013-3188-4","article-title":"Spicing things up: synthetic cannabinoids","volume":"228","author":"Spaderna","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2023.115053_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.psychres.2023.115053_bib0066","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/can.2018.0047","article-title":"Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: responders versus nonresponders","volume":"4","author":"Theunissen","year":"2019","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.psychres.2023.115053_bib0067","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0269881114565142","article-title":"The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects","volume":"29","author":"van Amsterdam","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2023.115053_bib0068","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000479554","article-title":"Synthetic cannabinoid use in a psychiatric patient population: a pilot study","volume":"23","author":"Welter","year":"2017","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.psychres.2023.115053_bib0069","article-title":"World medical association declaration of helsinki: ethical principles for medical research involving human subjects","year":"2013","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.psychres.2023.115053_bib71","unstructured":"United Nations, 2022. World Drug Report. United Nations, Office on Drug and Crime, Vienna."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:00:14Z","timestamp":1759039214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178123000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":68,"alternative-id":["S0165178123000069"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115053","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115053"}}